Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating polyneuropathy Read more
Alembic Pharma subsidiary, Alembic Global Holding SA gets USFDA final nod for Treprostinil injection Read more
AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19 Read more
Rhizen Pharma’s partnered asset Umbralisib gets US FDA accelerated nod for relapsed or refractory marginal zone lymphoma, follicular lymphoma Read more